Inhibits the expression of MHC class I and II molecules and antigen presentation in APCs and tumor cells. Contribute to immunosuppression by hindering the effector activity NK, Th1, and CD8+ T cells. Negatively correlates with tumor-infiltrating CD8+ IFN-γ+. Here, CD8A is linked to neoplasm.